Literature DB >> 18644983

Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.

Pei-Yao Liu1, James Yi-Hsin Chan, Hsiu-Chen Lin, Sung-Ling Wang, Shu-Ting Liu, Ching-Liang Ho, Li-Chien Chang, Shih-Ming Huang.   

Abstract

Zac1 is a novel seven-zinc finger protein which possesses the ability to bind specifically to GC-rich DNA elements. Zac1 not only promotes apoptosis and cell cycle arrest but also acts as a transcriptional cofactor for p53 and a number of nuclear receptors. Our previous study indicated that the enhancement of p53 activity by Zac1 is much more pronounced in HeLa cells compared with other cell lines tested. This phenomenon might be due to the coactivator effect of Zac1 on p53 and the ability of Zac1 to reverse E6 inhibition of p53. In the present study, we showed that Zac1 acted synergistically with either p53 or a histone deacetylase inhibitor, trichostatin A, to enhance p21(WAF1/Cip1) promoter activity. We showed that Zac1 physically interacted with some nuclear receptor corepressors such as histone deacetylase 1 (HDAC1) and mSin3a, and the induction of p21(WAF1/Cip1) gene and protein by Zac1 was suppressed by either overexpressing HDAC1 or its deacetylase-dead mutant. In addition, our data suggest that trichostatin A-induced p21(WAF1/Cip1) protein expression might be mediated through a p53-independent and HDAC deacetylase-independent pathway. Taken together, our data suggest that Zac1 might be involved in regulating the p21(WAF1/Cip1) gene and protein expression through its protein-protein interaction with p53 and HDAC1 in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644983     DOI: 10.1158/1541-7786.MCR-08-0123

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  19 in total

Review 1.  Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

Authors:  Teodora Ribarska; Klaus-Marius Bastian; Annemarie Koch; Wolfgang A Schulz
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

2.  Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis.

Authors:  Y-C Chen; J Y-H Chan; Y-L Chiu; S-T Liu; G Lozano; S-L Wang; C-L Ho; S-M Huang
Journal:  Cell Death Differ       Date:  2013-02-01       Impact factor: 15.828

Review 3.  PLAGL1: an important player in diverse pathological processes.

Authors:  Ana F Vega-Benedetti; Cinthia Saucedo; Patrizia Zavattari; Roberta Vanni; José L Zugaza; Luis Antonio Parada
Journal:  J Appl Genet       Date:  2016-06-16       Impact factor: 3.240

4.  microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.

Authors:  Aldo M Roccaro; Antonio Sacco; Xiaoying Jia; Abdel Kareem Azab; Patricia Maiso; Hai T Ngo; Feda Azab; Judith Runnels; Phong Quang; Irene M Ghobrial
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

5.  HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability.

Authors:  M Krishnan; A B Singh; J J Smith; A Sharma; X Chen; S Eschrich; T J Yeatman; R D Beauchamp; P Dhawan
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 6.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

Review 7.  Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology.

Authors:  Antonio Sacco; Ghayas C Issa; Yong Zhang; Yang Liu; Patricia Maiso; Irene M Ghobrial; Aldo M Roccaro
Journal:  J Hematol Oncol       Date:  2010-10-07       Impact factor: 17.388

8.  Chromatin remodeling, cell proliferation and cell death in valproic acid-treated HeLa cells.

Authors:  Marina Barreto Felisbino; Wirla M S C Tamashiro; Maria Luiza S Mello
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

9.  Characterization of a new mouse p53 variant: loss-of-function and gain-of-function.

Authors:  James Yi-Hsin Chan; Ying-Chuan Chen; Shu-Ting Liu; Wei-Yuan Chou; Ching-Liang Ho; Shih-Ming Huang
Journal:  J Biomed Sci       Date:  2014-05-08       Impact factor: 8.410

10.  Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes.

Authors:  Jeremie Boucher; Marika Charalambous; Kim Zarse; Marcelo A Mori; Andre Kleinridders; Michael Ristow; Anne C Ferguson-Smith; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.